LO loestrin FE 1-10 tablet 28S
Ended Awarded Last action
- Contract number
- SPE2DR26F47S6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,075
Award facts
- Contract value 100% obligated
- $1,074.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count packaging) under a firm fixed-price contract with a ceiling value of $1,074.58. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, holds a significant position as a critical vendor for federal medical procurement. The company's DLA contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for hormone therapy medication reflects the company's established role in supplying comprehensive pharmaceutical products to meet military healthcare procurement requirements through competitive, firm fixed-price delivery mechanisms.
Quick answers
Who was awarded contract SPE2DR26F47S6?
SPE2DR26F47S6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F47S6 worth?
The government has obligated $1,075 on SPE2DR26F47S6.
Is contract SPE2DR26F47S6 an order under another contract?
Yes. SPE2DR26F47S6 is a delivery order under SPE2DR25D3304, an indefinite delivery contract.
Was contract SPE2DR26F47S6 competed?
The extent of competition for SPE2DR26F47S6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award